Madison Technologies Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Madison Technologies Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2013 | Dec 31, 2013 | $144.0K | Mar 28, 2014 |
| FY2012 | Dec 31, 2012 | $144.0K | Mar 12, 2013 |
| FY2011 | Dec 31, 2011 | $144.0K | Apr 16, 2012 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2020 | Dec 31, 2020 | $1.4K | Jun 23, 2021 |
| FY2020 | Dec 31, 2019 | $5.0K | Jun 23, 2021 |
| FY2019 | Dec 31, 2018 | $4.4K | Apr 14, 2020 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $6.7K | Mar 29, 2018 |
| FY2017 | Dec 31, 2016 | $221 | Mar 29, 2018 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2020 | Dec 31, 2020 | $578 | Jun 23, 2021 |
| FY2020 | Dec 31, 2019 | $1.9K | Jun 23, 2021 |
| FY2019 | Dec 31, 2018 | $1.9K | Apr 14, 2020 |
| FY2018 | Dec 31, 2017 | $2.2K | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | $159 | Mar 29, 2018 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($2.98M) | Apr 17, 2026 |
| FY2025 | Dec 31, 2024 | ($2.80M) | Apr 17, 2026 |
| FY2024 | Dec 31, 2023 | ($5.30M) | Oct 30, 2025 |
| FY2023 | Dec 31, 2022 | ($12.91M) | Aug 22, 2025 |
| FY2022 | Dec 31, 2021 | ($14.26M) | Jan 25, 2024 |
| FY2021 | Dec 31, 2020 | ($910.2K) | Aug 26, 2022 |
| FY2020 | Dec 31, 2019 | ($42.3K) | Jun 23, 2021 |
| FY2019 | Dec 31, 2018 | ($53.9K) | Apr 14, 2020 |
| FY2018 | Dec 31, 2017 | ($53.3K) | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | ($42.2K) | Mar 29, 2018 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($499.7K) | Apr 17, 2026 |
| FY2025 | Dec 31, 2024 | ($302.2K) | Apr 17, 2026 |
| FY2024 | Dec 31, 2023 | ($567.2K) | Oct 30, 2025 |
| FY2023 | Dec 31, 2022 | ($3.65M) | Aug 22, 2025 |
| FY2022 | Dec 31, 2021 | ($4.64M) | Jan 25, 2024 |
| FY2021 | Dec 31, 2020 | ($117.4K) | Aug 26, 2022 |
| FY2011 | Dec 31, 2011 | ($30.4K) | Apr 16, 2012 |
| FY2011 | Dec 31, 2010 | ($24.4K) | Apr 16, 2012 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2020 | Dec 31, 2020 | $88.6K | Jun 23, 2021 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $188.3K | Apr 17, 2026 |
| FY2025 | Dec 31, 2024 | $54.1K | Apr 17, 2026 |
| FY2024 | Dec 31, 2023 | $426.8K | Oct 30, 2025 |
| FY2023 | Dec 31, 2022 | $719.6K | Aug 22, 2025 |
| FY2022 | Dec 31, 2021 | $8.5K | Jan 25, 2024 |
| FY2021 | Dec 31, 2020 | $29.6K | Aug 26, 2022 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($331.0K) | Apr 17, 2026 |
| FY2025 | Dec 31, 2024 | ($394.6K) | Apr 17, 2026 |
| FY2024 | Dec 31, 2023 | ($323.3K) | Oct 30, 2025 |
| FY2023 | Dec 31, 2022 | ($2.82M) | Aug 22, 2025 |
| FY2022 | Dec 31, 2021 | ($2.80M) | Jan 25, 2024 |
| FY2021 | Dec 31, 2020 | ($489.3K) | Aug 26, 2022 |
| FY2020 | Dec 31, 2019 | ($51.2K) | Jun 23, 2021 |
| FY2019 | Dec 31, 2018 | ($33.0K) | Apr 14, 2020 |
| FY2018 | Dec 31, 2017 | ($11.0K) | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | ($30.7K) | Mar 29, 2018 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2022 | Dec 31, 2021 | $167.0K | Jan 25, 2024 |
| FY2021 | Dec 31, 2020 | $10.0K | Aug 26, 2022 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $130.6K | Apr 17, 2026 |
| FY2025 | Dec 31, 2024 | $130.6K | Apr 17, 2026 |
| FY2024 | Dec 31, 2023 | $0 | Oct 30, 2025 |
| FY2023 | Dec 31, 2022 | $11.74M | Aug 22, 2025 |
| FY2022 | Dec 31, 2021 | $16.77M | Jan 25, 2024 |
| FY2021 | Dec 31, 2020 | $510.6K | Aug 26, 2022 |
| FY2020 | Dec 31, 2019 | $6.5K | Jun 23, 2021 |
| FY2019 | Dec 31, 2018 | $5.5K | Apr 14, 2020 |
| FY2018 | Dec 31, 2017 | $21.0K | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | $57.0K | Mar 29, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $23.44M | Apr 17, 2026 |
| FY2025 | Dec 31, 2024 | $20.52M | Apr 17, 2026 |
| FY2024 | Dec 31, 2023 | $17.59M | Oct 30, 2025 |
| FY2023 | Dec 31, 2022 | $24.11M | Aug 22, 2025 |
| FY2022 | Dec 31, 2021 | $20.44M | Jan 25, 2024 |
| FY2021 | Dec 31, 2020 | $668.5K | Aug 26, 2022 |
| FY2020 | Dec 31, 2019 | $364.9K | Jun 23, 2021 |
| FY2019 | Dec 31, 2018 | $371.7K | Apr 14, 2020 |
| FY2018 | Dec 31, 2017 | $398.2K | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | $426.0K | Mar 29, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($23.31M) | Apr 17, 2026 |
| FY2025 | Dec 31, 2024 | ($20.39M) | Apr 17, 2026 |
| FY2024 | Dec 31, 2023 | ($17.59M) | Oct 30, 2025 |
| FY2023 | Dec 31, 2022 | ($12.37M) | Aug 22, 2025 |
| FY2022 | Dec 31, 2021 | ($3.67M) | Jan 25, 2024 |
| FY2022 | Dec 31, 2020 | ($157.9K) | Jan 25, 2024 |
| FY2021 | Dec 31, 2019 | ($358.4K) | Aug 26, 2022 |
| FY2020 | Dec 31, 2018 | ($366.1K) | Jun 23, 2021 |
| FY2019 | Dec 31, 2017 | ($377.2K) | Apr 14, 2020 |
| FY2018 | Dec 31, 2016 | ($368.9K) | Apr 1, 2019 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | $4.22M | Jan 25, 2024 |
| FY2022 | Dec 31, 2021 | $4.22M | Jan 25, 2024 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($34.64M) | Apr 17, 2026 |
| FY2025 | Dec 31, 2024 | ($31.66M) | Apr 17, 2026 |
| FY2024 | Dec 31, 2023 | ($28.86M) | Oct 30, 2025 |
| FY2023 | Dec 31, 2022 | ($23.56M) | Aug 22, 2025 |
| FY2022 | Dec 31, 2021 | ($15.75M) | Jan 25, 2024 |
| FY2021 | Dec 31, 2020 | ($1.48M) | Aug 26, 2022 |
| FY2020 | Dec 31, 2019 | ($574.3K) | Jun 23, 2021 |
| FY2019 | Dec 31, 2018 | ($532.0K) | Apr 14, 2020 |
| FY2018 | Dec 31, 2017 | ($478.1K) | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | ($424.8K) | Mar 29, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2019 | Dec 31, 2019 | $1.4K | Apr 14, 2020 |
| FY2019 | Dec 31, 2018 | $2.5K | Apr 14, 2020 |
| FY2018 | Dec 31, 2017 | $3.3K | Apr 1, 2019 |
| FY2018 | Dec 31, 2016 | $14.3K | Apr 1, 2019 |
| FY2017 | Dec 31, 2015 | $501 | Mar 29, 2018 |
| FY2016 | Dec 31, 2014 | $3.2K | Mar 30, 2017 |
| FY2015 | Dec 31, 2013 | $9.9K | Mar 30, 2016 |
| FY2014 | Dec 31, 2012 | $4.0K | Mar 31, 2015 |
| FY2013 | Dec 31, 2011 | $3.2K | Mar 28, 2014 |
| FY2012 | Dec 31, 2010 | $1.8K | Mar 12, 2013 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | 0 | Jan 25, 2024 |
| FY2022 | Dec 31, 2021 | 0 | Jan 25, 2024 |
| FY2021 | Dec 31, 2020 | 0 | Aug 26, 2022 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 1.68B | Apr 17, 2026 |
| FY2025 | Dec 31, 2024 | 1.60B | Apr 17, 2026 |
| FY2024 | Dec 31, 2023 | 1.60B | Oct 30, 2025 |
| FY2023 | Dec 31, 2022 | 1.60B | Aug 22, 2025 |
| FY2022 | Dec 31, 2021 | 1.60B | Jan 25, 2024 |
| FY2021 | Dec 31, 2020 | 23.47M | Aug 26, 2022 |
| FY2020 | Dec 31, 2019 | 18.06M | Jun 23, 2021 |
| FY2019 | Dec 31, 2018 | 16.76M | Apr 14, 2020 |
| FY2018 | Dec 31, 2017 | 12.26M | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | 11.30M | Mar 29, 2018 |